Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.

Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection. Gastroenterology. 2010 Apr; 138(4):1365-73, 1373.e1-2.

View in: PubMed